Skip to content

FINPOP 2015: Incidence, Methods, Complications and Quality of Life of Pelvic Organ Prolapse Operations in Finland 2015

Finnish Pelvic Organ Prolapse Surgery Survey 2015: Incidence, Methods, Complications and Effect on Quality of Life of Pelvic Organ Prolapse Operations in Finland in 2015

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02716506
Enrollment
3515
Registered
2016-03-23
Start date
2015-01-31
Completion date
2025-01-31
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

POP surgery

Brief summary

The aim of this study is to investigate the safety and effectivity of pelvic organ prolapse (POP) surgery. In this multi center study the population consists of POP operations done in Finland year 2015.The study is prospective and validated questionnaires are used to measure the symptoms of POP and the quality of life before and six months after the operation. Methods and complications of surgery are reported by doctors in all 40 participant hospitals.

Detailed description

Patients awaiting for surgical procedure for a symptomatic pelvic organ prolapse (POP) are recruited for the study. The recruiting is done in 41 hospitals in Finland, at gynecological outpatient clinics. Participants are given information of the study and give a written approval to join the study. Participants are asked to fill in questionnaires, that measure the quality of life. Three validated questionnaires are used: Pelvic Floor Distress Inventory PFDI-20, Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire PISQ-12 and health-related quality of life instrument 15D. These questionnaires are sent to participants 6 months, 2 and 5 years after the surgical treatment. The participants are also asked to report adverse effects related to the treatment and their satisfaction to the treatment. Information about the surgical procedure (i.e. type and duration of the procedure, blood loss, antibiotic and thrombosis prophylaxis) by the operating doctors. Both immediate and delayed treatment-related adverse effects are also reported by the doctors. Data is partly collected by questionnaires filled in internet. All the collected data is protected by high security and coded before analyses. Permission of protocol used in this study is given by the Ethical Committee of University of Eastern Finland and Finnish National Institute for Health and Welfare.

Interventions

PROCEDUREPOP surgery

Any surgical procedure that is done to treat the symptomatic POP

Sponsors

Society for Gynecological Surgery in Finland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 120 Years
Healthy volunteers
Yes

Inclusion criteria

* Symptomatic pelvic organ prolapse * Mental and psychological ability to understand the study information and to give an approval * Knowledge of Finnish or Swedish language

Exclusion criteria

* Other than Finnish or Swedish language * Psychological disability to understand the study information

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life After the POP Surgery24 months after the surgeryQuality of life is measured by using 15 dimensional quality of health measurement instrument. Minimum value is 0 and maximum value is 1. Higher scores mean better outcome.

Secondary

MeasureTime frameDescription
Symptoms Related to Pelvic Organ Prolapse24 months after the surgeryCondition-specific questionnaire Pelvic Floor Distress Inventory (PFDI-20) is used. Minimum value is 0 and maximum value is 300. Higher scores mean more bothersome symptoms.

Countries

Finland

Participant flow

Participants by arm

ArmCount
Symptomatic POP
Patients that were operated for POP in 2015 in Finland and participated the study
3,512
Total3,512

Baseline characteristics

CharacteristicSymptomatic POP
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1748 Participants
Age, Categorical
Between 18 and 65 years
1764 Participants
Age, Continuous64.0 years
STANDARD_DEVIATION 10.7
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Finland
3512 Participants
Sex: Female, Male
Female
3512 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 3,512
other
Total, other adverse events
353 / 3,512
serious
Total, serious adverse events
15 / 3,512

Outcome results

Primary

Quality of Life After the POP Surgery

Quality of life is measured by using 15 dimensional quality of health measurement instrument. Minimum value is 0 and maximum value is 1. Higher scores mean better outcome.

Time frame: 24 months after the surgery

Population: Analysis of the patients who answered the 15-D questionnaire 24 months after the operation.

ArmMeasureValue (MEAN)
Symptomatic POPQuality of Life After the POP Surgery0.898 units on a scale
Secondary

Symptoms Related to Pelvic Organ Prolapse

Condition-specific questionnaire Pelvic Floor Distress Inventory (PFDI-20) is used. Minimum value is 0 and maximum value is 300. Higher scores mean more bothersome symptoms.

Time frame: 24 months after the surgery

Population: Change in PFDI-20 scores 24 months after the operation compared to the baseline scores.

ArmMeasureValue (MEAN)Dispersion
Symptomatic POPSymptoms Related to Pelvic Organ Prolapse49.24 score on a scaleStandard Deviation 44.61

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026